148 related articles for article (PubMed ID: 7563611)
1. [Vancomycin-induced thrombocytopenia for MRSA pneumonia].
Kishimoto T
Rinsho Ketsueki; 1995 Aug; 36(8):768-73. PubMed ID: 7563611
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of ME1036 against meticillin-resistant Staphylococcus aureus and vancomycin-insensitive S. aureus in a model of haematogenous pulmonary infection.
Yanagihara K; Ohnishi Y; Morinaga Y; Nakamura S; Kurihara S; Seki M; Izumikawa K; Kakeya H; Yamamoto Y; Yamada Y; Kohno S; Kamihira S
Int J Antimicrob Agents; 2008 Nov; 32(5):401-4. PubMed ID: 18715761
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin-induced thrombocytopenia without isolation of a drug-dependent antibody.
Ruggero MA; Abdelghany O; Topal JE
Pharmacotherapy; 2012 Nov; 32(11):e321-5. PubMed ID: 23065779
[TBL] [Abstract][Full Text] [Related]
4. [Effect of inhaled vancomycin hydrochloride on elimination of methicillin-resistant Staphylococcus aureus].
Shirai M; Ide K; Sato M; Murakami M; Tanaka Y; Sato A; Chida K
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1233-9. PubMed ID: 8583715
[TBL] [Abstract][Full Text] [Related]
5. Potency of DX-619, a novel des-F(6)-quinolone, in haematogenous murine bronchopneumonia caused by methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
Yanagihara K; Seki M; Izumikawa K; Higashiyama Y; Miyazaki Y; Hirakata Y; Tomono K; Mizuta Y; Tsukamoto K; Kohno S
Int J Antimicrob Agents; 2006 Sep; 28(3):212-6. PubMed ID: 16887340
[TBL] [Abstract][Full Text] [Related]
6. A holistic approach to MRSA eradication in critically ill patients with MRSA pneumonia.
Wenisch C; Laferl H; Szell M; Smolle KH; Grisold A; Bertha G; Krause R
Infection; 2006 Jun; 34(3):148-54. PubMed ID: 16804658
[TBL] [Abstract][Full Text] [Related]
7. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
Jeffres MN; Isakow W; Doherty JA; Micek ST; Kollef MH
Clin Ther; 2007 Jun; 29(6):1107-15. PubMed ID: 17692725
[TBL] [Abstract][Full Text] [Related]
8. Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia.
Scheetz MH; Wunderink RG; Postelnick MJ; Noskin GA
Pharmacotherapy; 2006 Apr; 26(4):539-50. PubMed ID: 16553514
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.
Maclayton DO; Hall RG
Ann Pharmacother; 2007 Feb; 41(2):235-44. PubMed ID: 17299012
[TBL] [Abstract][Full Text] [Related]
10. Methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia--a critical review.
Johnston BL
Semin Respir Infect; 1994 Sep; 9(3):199-206. PubMed ID: 7831542
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
Florescu I; Beuran M; Dimov R; Razbadauskas A; Bochan M; Fichev G; Dukart G; Babinchak T; Cooper CA; Ellis-Grosse EJ; Dartois N; Gandjini H;
J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i17-28. PubMed ID: 18684703
[TBL] [Abstract][Full Text] [Related]
12. Recognition and treatment of neonatal community-associated MRSA pneumonia and bacteremia.
Yee-Guardino S; Kumar D; Abughali N; Tuohy M; Hall GS; Kumar ML
Pediatr Pulmonol; 2008 Feb; 43(2):203-5. PubMed ID: 18085688
[TBL] [Abstract][Full Text] [Related]
13. [MRSA-induced prosthetic valve endocarditis complicated by synthetic graft infection that did not respond to repeated vancomycin administration but improved after surgery].
Tanaka K; Kido M; Sakurai Y; Otani H; Imamura H
Nihon Kyobu Geka Gakkai Zasshi; 1996 Sep; 44(9):1767-71. PubMed ID: 8911053
[TBL] [Abstract][Full Text] [Related]
14. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan.
Kohno S; Yamaguchi K; Aikawa N; Sumiyama Y; Odagiri S; Aoki N; Niki Y; Watanabe S; Furue M; Ito T; Croos-Dabrera R; Tack KJ
J Antimicrob Chemother; 2007 Dec; 60(6):1361-9. PubMed ID: 17913720
[TBL] [Abstract][Full Text] [Related]
15. Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms.
González C; Rubio M; Romero-Vivas J; González M; Picazo JJ
Clin Infect Dis; 1999 Nov; 29(5):1171-7. PubMed ID: 10524959
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Estes L; Orenstem R
Clin Ther; 2007 Apr; 29(4):759-60; author reply 760-1. PubMed ID: 17617300
[No Abstract] [Full Text] [Related]
17. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
Stevens DL; Herr D; Lampiris H; Hunt JL; Batts DH; Hafkin B
Clin Infect Dis; 2002 Jun; 34(11):1481-90. PubMed ID: 12015695
[TBL] [Abstract][Full Text] [Related]
18. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
Sakoulas G; Moellering RC
Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
[TBL] [Abstract][Full Text] [Related]
19. Daptomycin use after vancomycin-induced neutropenia in a patient with left-sided endocarditis.
Mergenhagen KA; Pasko MT
Ann Pharmacother; 2007 Sep; 41(9):1531-5. PubMed ID: 17652126
[TBL] [Abstract][Full Text] [Related]
20. Optimizing therapy for MRSA pneumonia.
Skrupky LP; Micek ST; Kollef MH
Semin Respir Crit Care Med; 2007 Dec; 28(6):615-23. PubMed ID: 18095225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
